
My Personal Substack
| Platform | Pricing | Only free issues | Publishes | Twice weekly | |
|---|---|---|---|---|---|
| Issues | 43 | Founded | a year ago | Last Issue | 7 days ago |
| Active | |||||

In today’s guest post, it’s my great pleasure to welcome Saroj Niraula, who recently commented, together with Ian Tannock, on a JCO study by Aaron Mitchell and colleagues showing how payments as small as $45 are associated with prescribing...
On October 22, 2026, just before the start of the ESMO Congress, I had the great honor and pleasure of giving a lecture at MD Anderson Cancer Center Madrid – Hospiten.
I also had the pleasure of sharing the stage with Prof. Sandra M. Swain...
Today I want to highlight two recent works we published about daraxonrasib and emerging RAS(ON) inhibitors in pancreatic cancer.
As a brief recap (if needed): the RASolute 302 trial marked a major advance, with daraxonrasib nearly doublin...
Today, 22 October 2026, I was honored to be invited to give a lecture at MD Anderson Cancer Center Madrid – Hospiten.
During my talk, I discussed the upcoming 6-year overall survival results of the NATALEE trial, which will be presented to...
Most of the time, we never get much further than the back cover of a book. Life is busy, and there are simply too many books to read. The same goes for scientific papers. We often stop at the abstract. There are simply too many publications...
Subscribers, engagement, traffic and sponsorship for The Oncology Shot with Timothee Olivier.
| Subscribers | Engagement | 74 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #116 |
The writers behind this newsletter.
Swiss oncologist at Geneva University Hospital. Research on trial methodology, health policy, and critical appraisal. I joined Vinay Prasad’s research lab in November 2021. Geneva Ethics Committee. Co-EiC ESMO Rare Cancers. No COI. Views mine.
Pharmacist Medicine & Society (PharmD-PhD), National Funder’s Committee for Evaluation of Specialised Medicines and Companion Diagnostics, CZ. Associate Professor of Medical Oncology, focused on Access to Medicines, LUMC, NL
Medical Oncologist and Translational Researcher, National Center for Cancer Immune Therapy, CCIT-DK, Copenhagen University Hospital, DK.
Clinician-Scientist, Oncologist, Professor of Immuno-Oncology National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark
You can find recent issues that have been published by The Oncology Shot with Timothee Olivier on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to The Oncology Shot with Timothee Olivier, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Oncology Shot with Timothee Olivier as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Oncology Shot with Timothee Olivier using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like The Oncology Shot with Timothee Olivier. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.